Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 453826, 8 pages
http://dx.doi.org/10.1155/2015/453826
Research Article

Antibacterial Activity of Synthetic Peptides Derived from Lactoferricin against Escherichia coli ATCC 25922 and Enterococcus faecalis ATCC 29212

1Sciences Faculty, Universidad Nacional de Colombia, Carrera 45, No. 26-85, Bogotá, Colombia
2Medicine Faculty, Universidad Nacional de Colombia, Carrera 45, No. 26-85, Bogotá, Colombia
3University Children’s Hospital, University of Würzburg, 97080 Würzburg, Germany

Received 30 July 2014; Accepted 24 September 2014

Academic Editor: Alejandra Ochoa-Zarzosa

Copyright © 2015 María A. León-Calvijo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization, Technical Consultation: Strategies for Global Surveillance of Antimicrobial Resistance, WHO, Geneva, Switzerland, 2013.
  2. L. H. Vorland, H. Ulvatne, J. Andersen et al., “Lactoferricin of bovine origin is more active than lactoferricins of human, murine and caprine origin,” Scandinavian Journal of Infectious Diseases, vol. 30, no. 5, pp. 513–517, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Andrä, K. Lohner, S. E. Blondelle et al., “Enhancement of endotoxin neutralization by coupling of a C12-alkyl chain to a lactoferricin-derived peptide,” Biochemical Journal, vol. 385, no. 1, pp. 135–143, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Romero, Microbiología y parasitología humana bases etiológicas de las enfermedades infecciosas y parasitarias, Editorial Médica Panamericana, Buenos Aires, Argentina, 2007.
  5. A. Shestakov, H. Jenssen, I. Nordström, and K. Eriksson, “Lactoferricin but not lactoferrin inhibit herpes simplex virus type 2 infection in mice,” Antiviral Research, vol. 93, no. 3, pp. 340–345, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. E. N. Baker and H. M. Baker, “A structural framework for understanding the multifunctional character of lactoferrin,” Biochimie, vol. 91, no. 1, pp. 3–10, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Farnaud and R. W. Evans, “Lactoferrin: a multifunctional protein with antimicrobial properties,” Molecular Immunology, vol. 40, no. 7, pp. 395–405, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Masschalck, R. van Houdt, and C. W. Michiels, “High pressure increases bactericidal activity and spectrum of lactoferrin, lactoferricin and nisin,” International Journal of Food Microbiology, vol. 64, no. 3, pp. 325–332, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. I. A. García-Montoya, T. S. Cendón, S. Arévalo-Gallegos, and Q. Rascón-Cruz, “Lactoferrin a multiple bioactive protein: an overview,” Biochimica et Biophysica Acta—General Subjects, vol. 1820, no. 3, pp. 226–236, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. P. F. Levay and M. Viljoen, “Lactoferrin: a general review,” Haematologica, vol. 80, no. 3, pp. 252–267, 1995. View at Google Scholar · View at Scopus
  11. B. Lönnerdal and S. Iyer, “Lactoferrin: molecular structure and biological function,” Annual Review of Nutrition, vol. 15, pp. 93–110, 1995. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Kuwata, T.-T. Yip, C. L. Yip, M. Tomita, and T. W. Hutchens, “Bactericidal domain of lactoferrin: detection, quantitation, and characterization of lactoferricin in serum by SELDI affinity mass spectrometry,” Biochemical and Biophysical Research Communications, vol. 245, no. 3, pp. 764–773, 1998. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Tomita, H. Wakabayashi, K. Shin, K. Yamauchi, T. Yaeshima, and K. Iwatsuki, “Twenty-five years of research on bovine lactoferrin applications,” Biochimie, vol. 91, no. 1, pp. 52–57, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. E. W. Odell, R. Sarra, M. Foxworthy, D. S. Chapple, and R. W. Evans, “Antibacterial activity of peptides homologous to a loop region in human lactoferrin,” FEBS Letters, vol. 382, no. 1-2, pp. 175–178, 1996. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Yamauchi, M. Tomita, T. J. Giehl, and R. T. Ellison III, “Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment,” Infection and Immunity, vol. 61, no. 2, pp. 719–728, 1993. View at Google Scholar · View at Scopus
  16. S. Farnaud, A. Patel, E. W. Odell, and R. W. Evans, “Variation in antimicrobial activity of lactoferricin-derived peptides explained by structure modelling,” FEMS Microbiology Letters, vol. 238, no. 1, pp. 221–226, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. A. M. Di Biase, A. Tinari, A. Pietrantoni et al., “Effect of bovine lactoferricin on enteropathogenic Yersinia adhesion and invasion in HEp-2 cells,” Journal of Medical Microbiology, vol. 53, no. 5, pp. 407–412, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. J. H. Andersen, S. A. Osbakk, L. H. Vorland, T. Traavik, and T. J. Gutteberg, “Lactoferrin and cyclic lactoferricin inhibit the entry of human cytomegalovirus into human fibroblasts,” Antiviral Research, vol. 51, no. 2, pp. 141–149, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Isamida, T. Tanaka, Y. Omata, K. Yamauchi, K. I. Shimazaki, and A. Saito, “Protective Effect of Lactoferricin against Toxoplasma gondii Infection in Mice,” Journal of Veterinary Medical Science, vol. 60, no. 2, pp. 241–244, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Jenssen, K. Sandvik, J. H. Andersen, R. E. W. Hancock, and T. J. Gutteberg, “Inhibition of HSV cell-to-cell spread by lactoferrin and lactoferricin,” Antiviral Research, vol. 79, no. 3, pp. 192–198, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Mistry, P. Drobni, J. Näslund, V. G. Sunkari, H. Jenssen, and M. Evander, “The anti-papillomavirus activity of human and bovine lactoferricin,” Antiviral Research, vol. 75, no. 3, pp. 258–265, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. J. S. Mader, D. Smyth, J. Marshall, and D. W. Hoskin, “Bovine lactoferricin inhibits basic fibroblast growth factor- and vascular endothelial growth factor165-induced angiogenesis by competing for heparin-like binding sites on endothelial cells,” The American Journal of Pathology, vol. 169, no. 5, pp. 1753–1766, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. J. S. Mader, J. Salsman, D. M. Conrad, and D. W. Hoskin, “Bovine lactoferricin selectively induces apoptosis in human leukemia and carcinoma cell lines,” Molecular Cancer Therapeutics, vol. 4, no. 4, pp. 612–624, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Richardson, R. de Antueno, R. Duncan, and D. W. Hoskin, “Intracellular delivery of bovine lactoferricin's antimicrobial core (RRWQWR) kills T-leukemia cells,” Biochemical and Biophysical Research Communications, vol. 388, no. 4, pp. 736–741, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. D. J. Schibli, P. M. Hwang, and H. J. Vogel, “The structure of the antimicrobial active center of lactoferricin B bound to sodium dodecyl sulfate micelles,” The FEBS Letters, vol. 446, no. 2-3, pp. 213–217, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. C. P. J. M. Brouwer, M. Rahman, and M. M. Welling, “Discovery and development of a synthetic peptide derived from lactoferrin for clinical use,” Peptides, vol. 32, no. 9, pp. 1953–1963, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Lloyd-Williams, F. Albericio, and E. Giralt, Chemical Approaches to the Synthesis of Peptides and Proteins, CRC Press, University of Barcelona, Barcelona, Spain, 1997.
  28. E. Kaiser, R. L. Colescott, C. D. Bossinger, and P. I. Cook, “Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides,” Analytical Biochemistry, vol. 34, no. 2, pp. 595–598, 1970. View at Publisher · View at Google Scholar · View at Scopus
  29. W. Kamysz, M. Okrój, E. Łempicka, T. Ossowski, and J. Łukasiak, “Fast and efficient purification of synthetic peptides by solid-phase extraction,” Acta Chromatographica, no. 14, pp. 180–186, 2004. View at Google Scholar · View at Scopus
  30. I. Wiegand, K. Hilpert, and R. E. W. Hancock, “Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances,” Nature Protocols, vol. 3, no. 2, pp. 163–175, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. B. E. Haug and J. S. Svendsen, “The role of tryptophan in the antibacterial activity of a 15-residue bovine lactoferricin peptide,” Journal of Peptide Science, vol. 7, no. 4, pp. 190–196, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Liu, F. Han, Y. Xie, and Y. Wang, “Comparative antimicrobial activity and mechanism of action of bovine lactoferricin-derived synthetic peptides,” BioMetals, vol. 24, no. 6, pp. 1069–1078, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. L. T. Nguyen, J. K. Chau, N. A. Perry, L. de Boer, S. A. J. Zaat, and H. J. Vogel, “Serum stabilities of short tryptophan- and arginine-rich antimicrobial peptide analogs,” PLoS ONE, vol. 5, no. 9, Article ID e12684, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Azuma, T. Kojima, I. Yokoyama et al., “Antibacterial activity of multiple antigen peptides homologous to a loop region in human lactoferrin,” Journal of Peptide Research, vol. 54, no. 3, pp. 237–241, 1999. View at Publisher · View at Google Scholar · View at Scopus
  35. K. S. Hoek, J. M. Milne, P. A. Grieve, D. A. Dionysius, and R. Smith, “Antibacterial activity of bovine lactoferrin-derived peptides,” Antimicrobial Agents and Chemotherapy, vol. 41, no. 1, pp. 54–59, 1997. View at Google Scholar · View at Scopus
  36. M. B. Strøm, Ø. Rekdal, and J. S. Svendsen, “Antibacterial activity of 15-residue lactoferricin derivatives,” Journal of Peptide Research, vol. 56, no. 5, pp. 265–274, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. M. B. Strøm, B. Erik Haug, Ø. Rekdal, M. L. Skar, W. Stensen, and J. S. Svendsen, “Important structural features of 15-residue lactoferricin derivatives and methods for improvement of antimicrobial activity,” Biochemistry and Cell Biology, vol. 80, no. 1, pp. 65–74, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. Ø. Rekdal, J. Andersen, L. H. Vorland, and J. S. Svendsen, “Construction and synthesis of lactoferricin derivatives with enhanced antibacterial activity,” Journal of Peptide Science, vol. 5, pp. 32–45, 1999. View at Google Scholar
  39. L. H. Vorland, H. Ulvatne, J. Andersen et al., “Antibacterial effects of lactoferricin B,” Scandinavian Journal of Infectious Diseases, vol. 31, no. 2, pp. 179–184, 1999. View at Publisher · View at Google Scholar · View at Scopus
  40. L. T. Nguyen, D. J. Schibli, and H. J. Vogel, “Structural studies and model membrane interactions of two peptides derived from bovine lactoferricin,” Journal of Peptide Science, vol. 11, no. 7, pp. 379–389, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Svenson, V. Vergote, R. Karstad, C. Burvenich, J. S. Svendsen, and B. de Spiegeleer, “Metabolic fate of lactoferricin-based antimicrobial peptides: effect of truncation and incorporation of amino acid analogs on the in vitro metabolic stability,” Journal of Pharmacology and Experimental Therapeutics, vol. 332, no. 3, pp. 1032–1039, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. P. H. Nibbering, E. Ravensbergen, M. M. Welling et al., “Human lactoferrin and peptides derived from its N terminus are highly effective against infections with antibiotic-resistant bacteria,” Infection and Immunity, vol. 69, no. 3, pp. 1469–1476, 2001. View at Publisher · View at Google Scholar · View at Scopus
  43. W. Bellamy, M. Takase, H. Wakabayashi, K. Kawase, and M. Tomita, “Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin,” Journal of Applied Bacteriology, vol. 73, no. 6, pp. 472–479, 1992. View at Publisher · View at Google Scholar · View at Scopus
  44. H. Wakabayashi, H. Matsumoto, K. Hashimoto, S. Teraguchi, M. Takase, and H. Hayasawa, “N-acylated and D enantiomer derivatives of a nonamer core peptide of lactoferricin B showing improved antimicrobial activity,” Antimicrobial Agents and Chemotherapy, vol. 43, no. 5, pp. 1267–1269, 1999. View at Google Scholar · View at Scopus
  45. P.-W. Chen, C.-L. Shyu, and F. C. Mao, “Antibacterial activity of short hydrophobic and basic-rich peptides,” The American Journal of Veterinary Research, vol. 64, no. 9, pp. 1088–1092, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. T. Z. Oo, N. Cole, L. Garthwaite, M. D. P. Willcox, and H. Zhu, “Evaluation of synergistic activity of bovine lactoferricin with antibiotics in corneal infection,” Journal of Antimicrobial Chemotherapy, vol. 65, no. 6, pp. 1243–1251, 2010. View at Publisher · View at Google Scholar · View at Scopus